繁體版 簡體版
 
 
Company Milestones  
Home > About Us > Company Milestones
 
 
2017
 
01 Launch of Hyaluronate Intravesical Instillation in Taiwan
02 Launch of Hyaluronate Absorbable Adhesion Barrier in Taiwan
03 European patent for the technique of Cross-linked Hyaluronic Acid Platform (CHAP) granted
06 Approval of Sedex Members Ethical Trade Audit (SMETA)
 
2016
 
03 Obtained the domestic medical device permits of HYADERMIS LA series Facial Dermal Implant with Lidocaine (including HYADERMIS Blink LA Facial Dermal Implant, HYADERMIS Kiss LA Facial Dermal Implant, HYADERMIS Smile LA Facial Dermal Implant and HYADERMIS Chic LA Facial Dermal Implant), were approved by Taiwan Food and Drug Administration (TFDA)
05 Launch of Wound Repair Hydrogel
06 USA’s patent for the technique of Cross-linked Hyaluronic Acid Platform (CHAP) granted
08 Signed an exclusive distribution agreement with GALDERMA S.A. (Subsidiary of Nestlé)
 
2015
 
10 Approval of Subsidy Project of Investing Development and Promoting Industry from Kaohsiung City Government
 
2014
 
04 Launch of Modified Sodium Hyaluronate Gel for Injection in China
Approval of on-site inspection by Korea Good Manufacturing Practice (KGMP) for medical device
05 Approval of access to Canadian Medical Devices Conformity Assessment System (CMDCAS)
 
2013
 
03 Taiwan’s patent for the technique of Cross-linked Hyaluronic Acid Platform (CHAP) granted
11 Japan’s patent for the technique of Cross-linked Hyaluronic Acid Platform (CHAP) granted Launch of IPOs (Initial Public Offerings) in Taiwan Launch of Hyaluronate Facial Dermal Implant with Lidocaine
12 Approval of Taiwan Intellectual Property Management System (TIPS)
 
2012
 
01 Synovial Fluid Supplement launched in Latvia, Belgium and Poland.
02 Launch of Hyaluronate Synovial Fluid Supplement Plus
06 Received Taiwan's patent approval.
10 Awarded by the 9th “National New Innovation Award” of the Institute for Biotechnology and Medicine Industry in Taiwan Awarded by the 2nd “National Industry Innovation Award” of the Ministry of Economic Affairs in Taiwan
 
2011
 
01 Facial Dermal Implant launched in Russia, Spain, Japan and Macau.
Synovial Fluid Supplement launched in Lithuania, Turkey, Malaysia and Estonia.
06 Patient Lubricant launched in Taiwan.
Received Taiwan and China patent approval.
 
2010
 
01 Facial Dermal Implant launched in Italy, Hong Kong, UK and Malaysia.
Synovial Fluid Supplement launched in Romania.
05 Received China patent approval.
06 Wound Healing Gel launched in Taiwan.
08 Obtained the SBIR governmental subsidy by Kaohsiung city government for Single-injection Synovial Fluid Supplement Mid-term R&D Project.
12 Listed on the GTSM, Taiwan with Emerging Stock Market Code 1786.
 
2009
 
01 Obtained the import license of Hya-Dermis Facial Dermal Implant in India.
Awarded with the “Leading Innovative Product Research and Development Program-Facial Dermal Implant of Crosslinked Hyaluronan” by the Ministry of Economic Affairs.
Facial Dermal Implant launched in Egypt, Kuwait and India.
Synovial Fluid Supplement launched in Jordan and Germany.
Obtained the LEADING governmental subsidy by IDB, MOEA for Crosslinked Hyaluronan R&D Project.
05 Listed as Biotech and New Pharmaceutical company by MOEA.
Obtained the ITDP governmental subsidy by DoIT, MOEA for Hya-Dermis Clinical Trial Project.
08 Obtained the SBIR governmental subsidy by Kaohsiung city government for Single-injection Synovial Fluid Supplement R&D Project.
 
2008
 
01 Medical device export permit for Ferovisc Synovial Fluid Supplement was issued by the Department of Health, Executive Yuan. Registration No. DOH-MD-(E)-No. 000068.
08 Obtained the import license of Hya-Joint Synovial Fluid Supplement in Jordan.
Hya-Joint Synovial Fluid Supplement was issued medical device permit by the Department of Health, Executive Yuan. Registration No. DOH-MD-No. 002490.
12 Hya-Joint Synovial Fluid Supplement was awarded “National Biomedical Quality Award”.
The medical device plant was accredited with the Class III medical device GMP certification by the Department of Health, Executive Yuan. GMP Registration No. 0970344235.
 
2006
 
01 Medical device export permit for Hya-Dermis Facial Dermal Implant was issued by the Department of Health, Executive Yuan. Registration No. DOH-MD-(E)-No. 000028.
Medical device export permit for Hya-Joint Synovial Fluid Supplement was issued by the Department of Health, Executive Yuan. Registration No. DOH-MD-(E)-No. 000029.
05 Certification extension of the biotechnology laboratory for parentage testing was approved by the TAF (Taiwan Accreditation Foundation).
08 Obtained the import license of Hya-Joint Synovial Fluid Supplement in India.
 
2005
 
01 Achieved the ISO 9001:2000 and ISO 13485:2003 Certification for Medical Device and Quality Management System.
03 Achieved the CE-MDD93/42/EEC (Class III) certification of Hya-Dermis Facial Dermal Implant. Obtained the CE marking CE0434, Certificate No. 2005-OSL-MDD-0037.
07 Awarded with the “Product Innovation Leadership Award of the Biomedical Material Category” from the Frost & Sullivan Awards.
09 The medical device plant was accredited with the Class III medical device GMP certification by the Department of Health, Executive Yuan. GMP Registration No. 0940325350.
12 Awarded with the “ Export Processing Zone Innovative Research and Development Award” from the Ministry of Economic Affairs.
Achieved the CE-MDD93/42/EEC (Class III) certification of Hya-Joint Synovial Fluid Supplement. Obtained the CE marking CE0434, Certificate No. 2006-OSL-MDD-0049.
 
2004
 
09 Awarded with the “Investment Incentive Program” by the Kaohsiung City Government.
 
2003
 
03 Achieved the CNLA Certification (The first certified parentage testing laboratory in Taiwan).
12 Awarded with incentive for “ Leading Innovative Product Research and Development Program-Medical Grade Hyaluronic Acid”by the Ministry of Economic Affairs.
 
2002
 
10 Achieved the ISO 9001 Certification.